Mar 15, 2021 Motus GI Announces First Patient Enrolled in a Pilot Study Using the Pure-Vu® System for Patients with Lower GI Bleeding Being Conducted by a Leading U.S. Medical Center
Mar 8, 2021 Motus GI to Present Pure-Vu GEN2 System at the Centers for Medicare and Medicaid Services ICD-10 Reimbursement Code Committee Meeting
Mar 2, 2021 Motus GI to Release Fourth Quarter and Full Year 2020 Results and Provide a Business Update on March 16
Feb 24, 2021 Motus GI Announces U.S. Patent for the Pure-Vu® System’s Connectivity with Nearly All Commercial Colonoscopes to Provide Improved Visualization During Colonoscopy
Jan 27, 2021 Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million
Jan 15, 2021 Motus GI Announces European Clearance of Enhanced Pure-Vu® GEN2 System to Harmonize with U.S. Configuration
Jan 11, 2021 Motus GI Expands Intellectual Property Portfolio with U.S. Patent for the Pure-Vu® System’s Universal Method to Mount on the End of Most Commercial Colonoscopes
